Answers are grounded in this paper and cite their sources.
The Metastatic Assay demonstrated significant prognostic performance in patients treated with radical radiotherapy both alone and independent of standard clinical and pathological variables. The Metastatic Assay could have clinical utility when deciding upon treatment intensification in high-risk patients. Genomic and clinical data are available as a public resource.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: